
FDA states end to Wegovy and Ozempic lack
The United State Fda revealed on Friday that it has actually formally revealed completion of nationwide lacks Ozempic and Wegovy medications for diabetes mellitus and weight reduction. The company initially revealed a scarcity of significant active ingredients for making Ozempic and Wegovy in 2022. The FDA’s statement comes months after drugmaker Novo Nordisk informed